Valosin-Containing Protein Stabilizes Mutant p53 to Promote Pancreatic Cancer Growth.

Cancer Research
Jieqiong WangHua Lu

Abstract

Approximately 80% of human pancreatic ductal adenocarcinomas (PDAC) harbor TP53 mutations, among which, R273H is the most frequent. Although p53-R273H is known to possess gain-of-function properties, how it is regulated in PDAC has not been extensively explored. Here we identify valosin-containing protein (VCP) as a regulator of p53-R273H by conducting immunoprecipitation-tandem mass spectrometry analysis. VCP bound p53-R273H at its DNA binding domain. Ectopic or endogenous VCP stabilized p53-R273H by binding to MDM2 and disrupting its association with mutant p53. Inhibition of VCP either by genetic depletion or the pharmacologic inhibitor CB-5083 increased ubiquitination and degradation of p53-R273H, leading to cell death. Consistently, ablation of VCP markedly retarded growth of cultured PDAC cells and xenograft PDAC tumors. Together, these results unveil VCP as a novel partner of p53-R273H in promoting PDAC growth and as a potential target for developing anti-PDAC therapy. SIGNIFICANCE: These findings identify valosin-containing protein (VCP) as a novel regulator of p53-R273H stability and suggest VCP as a potential target for development of pancreatic cancer therapy.

References

Mar 18, 2000·The Journal of Biological Chemistry·S FangA M Weissman
Feb 1, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shinji YamamotoKatsuyuki Aozasa
Jun 28, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shinji YamamotoKatsuyuki Aozasa
May 8, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yuichi TsujimotoKatsuyuki Aozasa
Jul 22, 2005·Investigational New Drugs·Basil F El-RayesPhilip A Philip
Mar 1, 2006·Molecular Cancer Therapeutics·Huiling YangMong-Hong Lee
Oct 3, 2007·Molecular and Cellular Biology·Natalia Lukashchuk, Karen H Vousden
May 17, 2008·Genes & Development·Tamara TerzianGuillermina Lozano
Jan 1, 2010·Nature Reviews. Drug Discovery·Aimee L Jackson, Peter S Linsley
Jul 20, 2010·Nature Structural & Molecular Biology·Masha V PoyurovskyCarol Prives
Nov 29, 2011·Nature Structural & Molecular Biology·Klara AcsNico P Dantuma
Jan 24, 2012·Cell·William A Freed-PastorCarol Prives
Feb 3, 2012·Nature Cell Biology·Hemmo MeyerSebastian Bremer
Jun 21, 2012·Genes & Development·William A Freed-Pastor, Carol Prives
Sep 12, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian D Lehmann, Jennifer A Pietenpol
Mar 4, 2014·Nature Biotechnology·Jeffry D Sander, J Keith Joung
Mar 22, 2014·Cancer Cell·Patricia A J Muller, Karen H Vousden
Aug 26, 2014·Journal of Cell Science·Hemmo Meyer, Conrad C Weihl
Mar 5, 2015·Journal of Molecular Cell Biology·Xiang ZhouHua Lu
Feb 3, 2016·Lancet·Terumi KamisawaKyoichi Takaori
Aug 19, 2016·Frontiers in Oncology·Pratikkumar Harsukhbhai VekariaRekha Rao
Dec 10, 2016·Cell Death and Differentiation·Evguenia M Alexandrova, Ute M Moll
Apr 30, 2017·Frontiers in Molecular Biosciences·Petra Hänzelmann, Hermann Schindelin
Sep 28, 2017·Nature Reviews. Clinical Oncology·Kanaga Sabapathy, David P Lane
Nov 21, 2017·Molecular Cell·Johannes van den Boom, Hemmo Meyer
Jan 26, 2018·JCI Insight·Heather K SchofieldMarina Pasca di Magliano
May 23, 2018·World Journal of Gastroenterology : WJG·Lulu ZhangAlina Stoita
Dec 7, 2018·Journal of Molecular Cell Biology·Xiang ZhouHua Lu
Jan 21, 2019·Gastroenterology·Laura D WoodMichael G Goggins
Feb 6, 2019·Nature Reviews. Gastroenterology & Hepatology·Eric A CollissonAndrew V Biankin
Mar 6, 2019·World Journal of Oncology·Prashanth RawlaVinaya Gaduputi
Jun 1, 2019·Laboratory Investigation; a Journal of Technical Methods and Pathology·Jinyu TangEric R Fearon
Jun 18, 2019·Pancreas·Gong-Qing ShenGareth Morris-Stiff
Dec 11, 2019·International Journal of Molecular Sciences·Yan SteinRonit Aloni-Grinstein
Jan 9, 2020·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Yan CuiDa Pang
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
Keyvan BehnamElsa J Brochmann
© 2021 Meta ULC. All rights reserved